search

Medica, one of the biggest medical technology trade fairs in the world, welcomes numerous international exhibitors and experts from the healthcare sector every year. Over 5,200 exhibitors will be present at this year’s edition, including several innovative Luxembourg companies that are advancing the frontiers of medical care.

By careful bio-engineering we create products that can be stored twice as long as the industry standard.

Poly Diagnostics, a recent graduate of the startup acceleration programme Fit 4 Start, will be part of the Luxembourg delegation at the Medica trade fair in Düsseldorf from 13 to 16 November. Myroslav Gebura, the company’s founder, is optimistic about the possibility for strategic alliances that will advance the company’s objective to improve healthcare through innovative IVD solutions. Luxembourg has a national pavilion in hall 3, stand A74.

What does your company offer in the field of health technologies?

Imagine you or your pet got sick and you would like to know what kind of pathogens caused the illness. Would you prefer to be tested for a single virus or bacteria at the time or for all the suspected causative agents at once?

Now suppose you are a doctor who has to perform the clinical test – would you like to spend 5 hours of time per test or you would like to finish it in less than 1 hour? Or maybe you would like to avoid buying specialised equipment for the storage of your reagents, or you would like your reagents to have a two-fold longer shelf life than the industry standard?

Being a part of Luxembourg’s vibrant and international community has been a source of inspiration. It’s a place where innovation thrives.

At Poly Diagnostics, we address exactly these issues and develop a portfolio of ready-to-use in-vitro diagnostic products in the dry format for the detection of multiple human pathogens at once.

By careful bio-engineering we create products that can be stored twice as long as the industry standard, have simple and user-friendly product handling, extraction-free IVD tests, less consumables (filter tips, mixing plates etc.), no storage equipment required, and products can be stored and transported at room temperature.

What is the objective of your participation at MEDICA?

Poly Diagnostics, as a Luxembourg-based startup specialising in instant format dry RT-PCR kits, aims to leverage its presence at Medica to solidify its position in the In Vitro Diagnostic (IVD) industry. By engaging with global healthcare professionals and experts, the company seeks to form strategic partnerships, gain industry insights, and boost its brand recognition, ultimately advancing its mission to enhance healthcare with innovative IVD solutions.

What has your experience been like as a startup in Luxembourg?

Our journey as a startup in Luxembourg has been nothing short of success. The pivotal moment in our trajectory was receiving the prestigious governmental support grant via the Fit 4 Start programme, which provided us with resources and guidance to continue our innovative endeavors.

The company seeks to form strategic partnerships, gain industry insights, and boost its brand recognition.

Luxinnovation, a dedicated governmental agency committed to nurturing startups, played a pivotal role in our growth too. Their unwavering support and mentorship have enabled us to refine our vision and strategies.

Being a part of Luxembourg’s vibrant and international community has been a source of inspiration. It’s a place where innovation thrives, and we are proud to contribute to this dynamic ecosystem. The collaborative spirit, the proximity to other forward-thinking companies, and the availability of facilities have all contributed to our success.

Photo credit: Poly Diagnostics

Read more

Entering the European market with ease

29-11-2023

In recent years, Luxembourg has emerged as a dynamic hub for innovation, boasting a robust ecosystem that encompasses a multitude of incubators, accelerators, specialised agencies, investors, and innovation hubs. This thriving ecosystem has played a pivotal role in nurturing and propelling numerous successful enterprises across diverse industries onto the global stage. Top executives leading some of Luxembourg’s key structures explain what the ecosystem offers and why this might just be the smartest and most cost-effective way for a soft-landing and to gain a foothold in foreign markets.
Read more

Pioneering “gamified neuroscience” for brain disorders

27-11-2023

Luxembourg-based company Myelin-H is developing a revolutionary software technology for the remote monitoring and management of neurological disorders. The company’s CEO, Zied Tayeb, sheds light on the company’s mission to make a difference and how a personal story sparked the conception of his startup.
Read more

Accessing the European healthtech market

22-11-2023

Healthtech solutions are subject to rather complex regulatory requirements guaranteeing health standards and protection in the EU. Luxembourg’s national innovation agency Luxinnovation manages a range of initiatives aimed at supporting healthtech companies from strategy development to European market access.
Read more

On the road to personalised medicine

20-11-2023

In 2008, the Luxembourg government launched its Sciences and Health Technologies Action Plan to diversify its economy, nurture health technology innovation and stimulate the shift towards personalised medicine. Fifteen years later, the country is home to internationally renowned biomedical research centres and a growing community of healthtech companies focusing, in particular, on digital health, digital medical devices and in vitro diagnostics.
Read more

Luxembourg’s rise to 2nd place in the IMD talent ranking

17-11-2023

In the 2023 IMD World Talent Ranking (WTR), Luxembourg moved up five spots to the second position. Its new ranking was influenced by its “strong performance” in the development of homegrown talents and access to an international talent pool.
Read more

Resources all news

Fermer